Compare ADMA Biologics Inc (ADMA) vs D Wave Quantum Inc (QBTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs D Wave Quantum Inc — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.22B), while D Wave Quantum Inc trades at $20.73 (market cap $7.53B). The key difference: D Wave Quantum Inc is far larger — about 3.4× ADMA Biologics Inc's market cap. Which is the better fit depends on your goals.
| ADMA | QBTS | |
|---|---|---|
Market Cap | $2.22B | $7.53B |
Sector | Health | Technology |
52-Week High | $20.38 | $44.78 |
52-Week Low | $7.60 | $12.98 |
Enterprise Value | $2.29B | $7.04B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About D Wave Quantum Inc
D-Wave Quantum Inc. is a global leader in the development and delivery of quantum computing systems, software, and services. The company specializes in annealing quantum computers designed to solve complex optimization problems across industries such as logistics, materials science, and financial modeling. D-Wave offers its technology through the cloud, allowing customers to build and run real-world quantum applications today, making it a key player in the commercialization of quantum computing.
Read more on QBTS →
